 2012 Seminar Schedule
MCB/ECH 294 Seminar - 2013 Spring Schedule
All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated
April 5, 2013
LSA 1022
|
Organizational Meeting
Dr. Judy Kjelstrom, course co-instructor
Director, Biotechnology Program
http://www.biotech.ucdavis.edu/Directors/director.html |
April 12, 2013
LSA 1022 |
Disrupting the Target and Antibody Discovery Paradigms
Mary Haak-Frendscho, PhD - CEO
Mark Flory, PhD - Principal Scientist, Discovery Research
Ingenica, Inc, Burlingame |
April 19, 2013
LSA 1022 |
Evaluating the Safety of Ocular Biotherapeutics - A Step in the Journey From Benchtop to Improving Vision
Brian Short, DVM, PhD, DACVP - Senior Director of Pathology
Allergan, Irvine |
April 26, 2013
LSA 1022 |
Parallel Revolutions: How Breakthroughs in Electronics and Biolgy are Converging at the Molecular Level
James N. Hollenhorst, PhD - Senior Director of Technology
Agilent Technologies, Santa Clara
|
May 3, 2013
LSA 1022
|
Seed Business: Genomics Assisted Plant Breeding or Plant Biotech?
Eleni Bachlava, PhD - Trait Geneticist, Vegetable Seeds
Monsanto, Woodland
|
May 10, 2013
LSA 1022 |
History of a Paradigm-Busting Therapy for Breast Cancer ... Herceptin
H. Michael Shepard, PhD - Chief Scientific Officer & Co-Inventor of Herceptin
Halozyme Therapeutics, Inc., San Diego
|
May 17, 2013
LSA 1022 |
Strategic Integration of Next Generation Sequencing Technologies
Gina Costa, PhD - Senior Director, Genetic Analysis
Life Technologies, Carlsbad, CA |
May 24, 2013
LSA 1022
|
Seed Business: Genomics-Assisted Plant Breeding or Plant Biotech?
Roger Sabbadini, PhD - Vice President and Founder
Loath, Inc., San Diego, CA |
May 31, 2013
LSA 1022 |
Creation of High Value Drugs and Food Ingredients with Metabolic Engineering
Riccardo LoCascio, PhD - Manager, Business Development
Evolva SA., San Francisco, CA |
|
|
MCB/ECH 294 Seminar - 2013 Winter Schedule
All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated
January 11, 2013
LSA 1022
|
Organizational Meeting
Dr. Judy Kjelstrom, course co-instructor
Director, Biotechnology Program
http://www.biotech.ucdavis.edu/Directors/director.html |
January 18, 2013
LSA 1022 |
Reversible Covlent Inhibition: An Optimal Approach to Achieve Highly Potent, Selective and Durable Inhibitors of Cysteine Containing Targets
David M. Goldstein, PhD - V.P. Drug Discovery
Principia Biopharma, S. San Francisco |
January 25, 2013
LSA 1022 |
Moving From Technical Operations to Serial Entrepreneur
Brock Siegel, PhD - Director
Life Science Angels, Ruubix Inc., Moleculo Inc., Rapid Diagnostek Inc., San Francisco
Presentation Available HERE
|
February 1, 2013
LSA 1022 |
Human Clinical Nutrition Research - A Critical Part of Translational Science
Marta Van Loan, PhD, FACSM - Research Physiologist and Adjunt Professor
USDA, WHNRC - UC Davis
|
February 8, 2013
LSA 1022
|
30 Years of Therapeutic Protein Production from Recombinant CHO Cells
Matthew Croughan, PhD - Rathmann Professor
Keck Graduate Institute, Los Angeles
|
February 15, 2013
LSA 1022 |
Development of Novel Therapeutics With Advanced Polymer Conjugate Technologies
Steve Doberstein, PhD - Chief Science Officer
Nektar Therapeutics, S. San Francisco
|
February 22, 2013
Genome Center Auditorium |
Joint Seminar with CREATE-IGERT Symposium
Rachel Chikwamba, PhD - Chief Scientist
Council for Scientific and Industrial Research (CSIR), South Africa |
March 1, 2013
LSA 1022
|
An Alternate Career for a PhD Scientist
Kimberly Barnholt, PhD - Research Programs & Alliances Manager
23andMe, Mountain View, CA |
March 8, 2013
LSA 1022 |
Opportunities at the Intersection of Biology and Silicon
Madoo Varma, PhD - Head and Director, Rsearch
Integrated Biosystems Lab at Intel Corp., San Francisco |
March 15, 2013
LSA 1022 |
Regenerative Medicine Studies Ongoing at UC Davis and Beyond
Jan Nolta, PhD - Professor, Director
UC Davis Institute for Regenerative Cures, UC Davis |
UC Davis Biotechnology Program ©2012 |
Technical Short Courses
Designated Emphasis in Biotechnology Program
Advanced Degree Program
Outreach